Musk's Neuralink says the FDA approved human trials

Elon Musk's brain-implant company Neuralink on Thursday said it had received U.S. regulatory approval for human trials for the first time -- a major milestone for the company after an earlier rejection reportedly over safety concerns. Diane To with the details.